BAX as reported
Baxter International reported $11.3B of revenue over the trailing twelve months, +5.1% on the year before. 11 reported series are charted on this page, each one as filed.
$11.3B
Revenue, trailing twelve months · to Q1 2026 · +5.1% against the twelve months before
- Net Income
- −$1.10B
Net Income · +96% year on year · trailing twelve months to Q1 2026
- Op Margin
- −2.3%
Op Margin · trailing twelve months to Q1 2026
- EPS
- −$2.14
EPS · +96% year on year · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $11.3B | +5.1% | Q1 2026 |
| Net Income | −$1.10B | +96% | Q1 2026 |
| EPS | −$2.14 | +96% | Q1 2026 |
| Gross Margin | 30% | n/a | Q1 2026 |
| Op Margin | −2.3% | n/a | Q1 2026 |
| Net Margin | −9.2% | n/a | Q1 2026 |
| ROE | −10% | n/a | Q1 2026 |
| ROA | −3.2% | n/a | Q1 2026 |
| ROIC | −1.8% | n/a | Q1 2026 |
| Free Cash Flow | $1.15B | n/a | Q4 2023 · 9 quarters behind |
| P/E | 49.5 | n/a | Q3 2024 · 6 quarters behind |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Baxter International (BAX) - Revenue & ProfitRevenue & ProfitBaxter International (BAX)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #20 of 27 by Smart Score